Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022. Read More Top 100 Best Sellers

Edifice Engineering, the company hired by Supertech to carry out the demolition, has completed 70 per cent of the rigging work in the taller tower Apex while the charging work of Ceyan, the smaller tower, with explosives has already been… Read More »Twin tower demolition: Taller tower 70% rigged, on track to meet August 23 deadline

Motilal Oswal recommended Neutral rating on Clean Science and Technology with a target price of Rs 1660 in its research report dated August 19, 2022. Read More Top 100 Best Sellers

Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 950 in its research report dated August 18, 2022. Read More Top 100 Best Sellers

Architect Ashams Ravi’s family home in Kerala’s Thiruvananthapuram is high on aesthetic appeal despite having a lower than low carbon footprint Top 100 Best Sellers Read More

Winds are blowing clearly in India’s favour despite all the odds, according to the latest State of the Economy report. Are investors listening? Top 100 Best Sellers Read More

The Dow Jones Industrial Average fell 0.86%, to 33,706.15, the SP 500 lost 1.29%, to 4,228.37, and the Nasdaq Composite dropped about 2%, to 12,705.22. Top 100 Best Sellers Read More

India is among the strongest economies in the world and is likely to remain so in the near and medium-term future. Top 100 Best Sellers Read More

In this week, Indian rupee slipped 13 paise to end at 79.78 per dollar on August 19 against its August 12 closing of 79.65. Read More Top 100 Best Sellers

In this week, Indian rupee slipped 13 paise to end at 79.78 per dollar on August 19 against its August 12 closing of 79.65. Read More Top 100 Best Sellers